Lux Health Tech Acquisition Corp.
Liquidated 2022-10-07- CIK 1823767
- LUXA
- IPO 2020-10-28
- $346M trust
- 63 filings
- IPO Size
- $345M
- raised at the IPO
- Trust
- $346M
- as of 2022-06-30
- Current Status
- Failed
- from its latest filing
- IPO Year
- 2020
- year it listed
Filings, by quarter
63 filings over 11 quarters; violet bars carry a milestone
- 20 Q3: 1 filing
- 20 Q4: 24 filings
- 21 Q1: 7 filings
- 21 Q2: 6 filings
- 21 Q3: 1 filing
- 21 Q4: 4 filings
- 22 Q1: 5 filings
- 22 Q2: 2 filings
- 22 Q3: 9 filings
- 22 Q4: 3 filings
- 23 Q1: 1 filing
- S-1 filed 20 Q3
- IPO 20 Q4
- Liquidated 22 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Lux Health Tech Acquisition Corp. is a blank-check company seeking a business combination, with an intended focus at the intersection of healthcare and technology, while retaining the ability to pursue any industry.
Investment Focus
Healthcare, Technology
Key Information
As the filings state it
- IPO Date
- 2020-10-28
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Failed Date
- 2022-10-07
- SPAC Ticker
- LUXA
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team is led by Lux Capital co-founder and managing partner Peter Hébert, healthcare technology executive Josh DeFonzo, and Lux Capital CFO Segolene Scarborough, with director nominees experienced in healthcare investing, government, and medical technology. Lux is described as having a 20-year investment track record and more than 130 active investments.